πŸ‡ΊπŸ‡Έ FDA
Patent

US 7763255

Therapeutic uses of Dunaliella powder

granted A61KA61K31/192A61K31/216

Quick answer

US patent 7763255 (Therapeutic uses of Dunaliella powder) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/192, A61K31/216, A61K31/426, A61K31/427